Through the partnership CORE Diagnostics will offer Paradigm’s most advanced cancer profiling services in India that will help improve treatment mechanisms
New Delhi, May 18, 2016: Indian medical startup CORE Diagnostics has entered into a new partnership with leading US-based molecular diagnostics company Paradigm to bring to India the latter’s advanced cancer profiling service, PCDx, which helps in detailed personalizing of each cancer patient’s course of treatment.
Paradigm, the molecular information & Next Generation Sequencing (NSG) corporation specializing in providing tumor analysis for patients with cancer to help find the optimal treatments, has signed a distribution agreement with CORE Diagnostics to facilitate patient access to PCDx, in India. Through this association, the two companies aim to provide a growing community of oncologists the most relevant and actionable cancer care available.
With molecular testing driving the new wave of personalized cancer treatment protocols, this agreement with enable CORE Diagnostics add a valuable service to its comprehensive menu of advanced diagnostic tests in India.
(Paradigm Cancer Diagnostic) PCDx is a comprehensive clinical-grade NGS-based test that is designed to provide physicians and patients with a more targeted, personalized approach to cancer treatment by identifying the underlying genomic and proteomic alterations of a tumors DNA, RNA & Protein. The test interrogates the most relevant genomic targets at over 5,000x average depth of coverage with 72 therapeutic associations. Results are typically delivered in 4-5 business days.The test uses molecular data to help oncologists provide the most effective treatment plan for each patient and devise more accurate therapeutic options for patient care.
“With a focus on esoteric testing, an extensive experience in the region, and a dedicated diagnostics sales team of over 40, CORE is an ideal partner to Paradigm as it seeks to expand the reach of its PCDx tumor profiling service,” said Zoya Brar, Founder & Managing Director of CORE Diagnostics. “Paradigm’s offering would be a great addition to our portfolio. We are looking forward to this relationship with Paradigm and believe it will have a significant impact on improving the treatment of cancer patients in India.”
David Mallery, President, Paradigm, said: “Expanding our testing services outside the US market is a key strategic initiative for Paradigm. The relationship with CORE Diagnostics provides us with considerable resources to rapidly expand testing and realize this goal while allowing better patient and physician access to PCDx abroad.”
CORE Diagnostics, offers a comprehensive menu of specialized, advanced diagnostic testing in India in the areas of cardiology, oncology, reproductive disorders, endocrinology and infectious diseases. It is also working with physicians from prominent medical centers in the U.S. to collaborate with their Indian colleagues. The company deploys next generation sequencing and other technologies in clinical applications and uses digital pathology for enabling concurrent global review of test results. The company also provides patients with peace of mind by delivering second opinions on all cases by at least two specialists from a global panel of pathologists.
About CORE DIAGNOSTICS
CORE Diagnostics is a clinical laboratory focused on next generation diagnostics for disease stratification and therapy selection. The company focuses on bringing the most advanced testing techniques and expertise to India and is the destination for all of India’s high-end diagnostic needs.
CORE Diagnostics is truly one of a kind, because of: A rich menu of high-end tests; second opinion on every test from a global panel of pathologists; and very short turnaround time. The company’s initial test offerings have been in the areas of cardiology, oncology, reproductive disorders, endocrinology, and infectious diseases. For more information, please visit www.corediagnostics.in.
About PARADIGM
Paradigm is a molecular information corporation established to bring cutting-edge diagnostics to cancer patients and industry by providing information about the genomic makeup of the patient’s cancer and potential therapies based on the specific characterization of the patient’s tumor that can impact the patient’s course of treatment. Paradigm’s Next-Generation Sequencing based diagnostic test PCDx provides oncologists and patients with more precise information about the specific cancer pathways in the patient and associations between the pathways and the specific drugs available that can affect the cancer to allow for more effective decision-making. The test is driven by supporting data and literature and provides more choices for patient care than currently available on the market. For more information visithttp://www.paradigmdx.org or visit us on Twitter @Paradigm_DX
CANNABIS OIL CURED MY WIFE BREAST CANCER
My wife is cancer free now after 4 years of bullshit with the Canadian and American medical systems. Never again will I put life in the hands of such medical doctors and health workers. They are not trying to help you and they are trying to suck money out of you then kill you with drugs “cancer fighting” poisons, surgeries and chemotherapy.My wife started to use cannabis oil after i was told she will die in a few months. I saw online where National Cancer Institute acknowledges that cannabis oil will kill cancer completely and i contacted the institute via email nationalcancerinstitute@aol.com and i was directed to where i could get high grade quality cannabis oil. My wife started ingesting about a half gram to a gram a day. Within 2 months and the cancer started to retreat. (breast cancer) She is now cancer free and it only took 3 months with the oil. she was using chemo and radiation for years before discovering cannabis oil and we told our doctor about the cannabis oil, My doctor said he can not comment on the use of cannabis and its effect on cancer. Although he saw that my wife cancer was cured with cannabis oil.
At this point, anyone who claims cannabis oil doesn’t have some impact on killing cancer cells is in a serious state of denial. I just can’t wait until this widely acknowledged truth is on an official level and we can see cannabis oil properly researched for further focused benefits.